EDGAR Filing Documents for 0001493152-23-024354

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

SEC Accession No. 0001493152-23-024354

Filing Date

2023-07-12

Accepted

2023-07-12 17:29:53

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		formf-1a.htm	F-1/A	652083
2		ex4-1.htm	EX-4.1	124301
3		ex4-2.htm	EX-4.2	139521
4		ex4-3.htm	EX-4.3	114613
5		ex4-4.htm	EX-4.4	154928
6		ex5-1.htm	EX-5.1	16198
7		ex5-2.htm	EX-5.2	18255
8		ex10-14.htm	EX-10.14	139618
9		ex10-15.htm	EX-10.15	252778
10		ex23-1.htm	EX-23.1	5159
11	CALCULATION OF FILING FEE TABLES	ex107.htm	EX-FILING FEES	35686
12		ex5-1_001.jpg	GRAPHIC	6373
13		ex5-1_002.jpg	GRAPHIC	6373
14		ex5-2_001.jpg	GRAPHIC	2950
15		formf-1a_001.jpg	GRAPHIC	7495
	Complete submission text file	0001493152-23-024354.txt		1686524

Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317

Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448

Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)